Concepción Palomo

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Laurent Detalle, Thomas Stöhr, Concepción Palomo et al. · Antimicrobial Agents and Chemotherapy · 2015 · 289 citations · Full text

Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides

Alfonsina Trento, Mónica Galiano, Cristina Videla et al. · Journal of General Virology · 2003 · 283 citations

Viral Replication, Major Changes, Genetics +16

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

Margarita Magro, Vicente Más, Keith J. Chappell et al. · Proceedings of the National Academy of Sciences · 2012 · 265 citations · Full text

Respiratory Virus Immunity, Immunology, Viral Pathogenesis +19

Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins

Blanca García‐Barreno, Concepción Palomo, C Peñas et al. · Journal of Virology · 1989 · 177 citations · Full text

Vaccination, Virus Structure, G Glycoproteins +13

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

Morgan S. A. Gilman, Syed M. Moin, Vicente Más et al. · PLoS Pathogens · 2015 · 137 citations · Full text

Prefusion-specific Antibody, Rsv Fusion, Respiratory Virus Immunity +17